Lumea’s Digital Diagnostic Suite™ (Viewer+™) Receives FDA 510(k) Clearance* for Clinical Diagnosis LEHI, UTAH, UNITED STATES, March 18, 2025 /EINPresswire.com/ – Lumea, a leader in digital pathology solutions, is proud…
Read More
Lumea and Myriad Genetics have partnered to integrate Myriad’s Prolaris® and MyRisk® molecular diagnostic tests into Lumea’s BxLink™ digital pathology platform. LEHI, UT, UNITED STATES, February 5, 2025 /EINPresswire.com/ --...
Read More
Lumea partners with Mindpeak to integrate AI tools like Breast Suite and Gleason grading into its platform, advancing precision in digital pathology. LEHI, UT, UNITED STATES, January 28, 2025 /EINPresswire.com/...
Read More
LEHI, UT, UNITED STATES, December 5, 2024 /EINPresswire.com/ — Lumea, a leader in digital pathology solutions, is excited to announce that Cxbladder™, a suite of non-invasive genomic urine tests optimized…
Out of 150 companies recognized, Lumea secured the 33rd spot in the prestigious 2024 Top Workplace Awards LEHI, UT, UNITED STATES, October 16, 2024 - Lumea has been recognized as a Top...
Read More
Park City, UT — August 22, 2024 — Nestled at the base of the breathtaking Wasatch Mountains in picturesque Park City, Utah, the Digital Diagnostic Summit will gather the brightest…
